Additionally, the overexpression of GGPS1, FDPS, GART, and 3-hydroxy-3-methylglutaryl-CoA synthase 1 (HMGCS1) was also associated with a highly significant overall reduction in the survival duration of patients with esophageal and pancreatic cancers. The gene discussed is HMGCS1; the disease is pancreatic neoplasm.